Entrepreneurship Centre students make the 21toWatch shortlist

Working on a diverse range of science and technology research innovations from cellular reprogramming solutions, personalised cancer treatment, wearable medtech devices, through to optimising energy usage and reducing carbon emissions, these entrepreneurs are making a meaningful impact.

Some of those recognised started their entrepreneurial journey at the EnterpriseTECH or EnterpriseWOMEN programmes, learning key skills, developing an entrepreneurial mindset and understanding better how to apply innovations for real-world impact which operate in a commercial environment. Others have started building the foundations for their own new venture at the intense Ignite week or progressed further through the startup accelerator, Accelerate Cambridge.

Cambridge Judge Entrepreneurship Centre people recognised in the shortlist

Arkoprovo Paul (Arko)

The Co-Founder of Oltera, which is focused on reprogramming immune cells as living drugs, is an EnterpriseTECH STAR alumnus.

Luke Cullen

The Founder of Just Decarbonise, a platform for automating carbon emissions estimates in supply chains, is an EnterpriseTECH STAR alumnus.

Jiayin Hong

A Research Associate at the University of Cambridge specialising in precision epigenetics to provide efficient cellular reprogramming solutions, offering customised cells for research, therapeutic and regenerative medicine, Jiayin is an EnterpriseTECH STAR alumnus.

Jonathan Fisher

The Founder of Peter, a medtech startup working on a device that will allow millions of Parkinson’s Disease sufferers to walk with freedom, control and confidence again, is participating in Accelerate Cambridge.

Dr Anna-Maria Kypraiou

The Founder of Eyesea Green, Anna-Maria is an EnterpriseTECH alumna and inventor who also participated in Accelerate Cambridge in 2022.

Lucy Jung

The Co-founder of LYEONS Neurotech, which is developing non-invasive solutions to support people with anxiety, depression and sleep disorders caused by neurological conditions, joined Accelerate Cambridge in 2025.

Raifa Al Maamari

A doctoral researcher at the University of Cambridge whose research focuses on implementing low-carbon hydrogen energy in the GCC countries in the Middle East, Raifa is an EnterpriseWOMEN and EnterpriseTECH alumna.

Austin Reed

The Founder and CEO of IntercepTx, a startup aiming to revolutionise cancer treatment by pioneering early intervention tools to prevent tumours before they develop, is an Ignite 2024 alumnus and is currently participating in Accelerate Cambridge.

Ping Lin Yeap

A doctoral researcher at the University of Cambridge and Founder of SynPixels (a company offering tailored cancer radiation therapies using AI-powered software to improve precision), Ping Lin is an EnterpriseTECH STAR alumnus and currently participating in Accelerate Cambridge.

Dr Ethan Waisberg

An Academic Foundation Doctor at the University of Cambridge, and Member of NASA’s Artificial Intelligence and Machine Learning Working Group, Ethan is the Founder of AngioGenius, a generative AI platform where a simple photo of the eye can be turned into another imaging type that provides more rich data, allowing disease progression to be better monitored. Ethan is an alumnus of Accelerate Cambridge (2024).

Companies supported by Cambridge Judge Entrepreneurship Centre that have been shortlisted for the awards

Alceus Bio

Alceus Bio, whose founders are EnterpriseTECH alumni, is pioneering the first class of multimodal CAR T therapies, targeting solid cancers in multiple ways to prevent cancer resistance and improve therapeutic outcomes.

Cellestial Health

Cellestial Health is a pharmacological discovery company protecting the neglected half of the brain composed of astrocytes – to stop the progression of Parkinson’s disease from the time of diagnosis. The founders contributed as inventors to EnterpriseTECH and participated in Ignite in 2024.

Clock.bio

Clock.bio’s founders are EnterpriseTECH alum. The company aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells.

A game-changing innovation for people with dementia and their carers

And finally, Supersense Technologies, an at-home monitoring service that protects the privacy and independence for people with dementia while making caring easier for families, has been nominated as one of the game-changing innovations in the ‘Things’ awards category. The Founders are EnterpriseTECH alumni and are currently participating in Accelerate Cambridge Plus.

21toWatch is organised by technology PR and communications agency, cofinitive – a Cambridge Management Consulting (Cambridge MC) company – and supported by the Cambridge Independent newspaper. The shortlist was announced on Wednesday 5 February, with the annual 21toWatch Top21 unveiled at an exclusive event on Thursday 6 March.